Meta-unstable mRNAs in activated CD8+ T cells are defined by interlinked AU-rich elements and m6A mRNA methylation
CD8<sup>+</sup> T cells can rapidly produce effector molecules following activation. This activation triggers rapid changes in gene expression that rely on the control of mRNA levels via multiple mechanisms, including RNA modifications. N<sup>6</sup>-methyladenosine (m<sup>6</sup>A) is an abundant post-transcriptional modification that promotes the decay of messenger RNAs in the cytosol. However, how recognition of m<sup>6</sup>A sites is integrated with other regulatory mechanisms that alter the fate of immunoregulatory mRNAs in CD8<sup>+</sup> T cells remains unexplored. Here, we apply the m<sup>6</sup>A-iCLIP and GLORI methods to identify the importance of m<sup>6</sup>A sites flanked by AU-rich elements (AREs) within the 3'UTRs of CD8<sup>+</sup> T cell mRNAs. Presence of such ARE-flanking m<sup>6</sup>A motifs predicts meta-unstable mRNAs that rapidly decay upon CD8<sup>+</sup> T cell activation. We demonstrate interdependent effects of mutations in the identified AREs and RRACHs on TNF mRNA stability. The ARE-flanking m<sup>6</sup>A sites in these mRNAs show particularly high iCLIP crosslinking of YTHDF proteins, which are also identified by proteomic interactome analyses along with additional novel RNA-binding proteins. Our study reveals a crosstalk between m<sup>6</sup>A and ARE-dependent mechanisms in CD8<sup>+</sup> T cells, providing new approaches for modulating mRNA decay in T cell activation.
Authors
- Paulo A. Gameiro (ORCID: https://orcid.org/0000-0001-8176-4237)
- Klara Kuret (ORCID: https://orcid.org/0000-0002-8445-8080)
- Nordin D. Zandhuis (ORCID: https://orcid.org/0000-0001-6628-3726)
- Michiel Vermeulen (ORCID: https://orcid.org/0000-0003-0836-6894)
- Jernej Ule (ORCID: https://orcid.org/0000-0002-2452-4277)
- Iosifina P. Foskolou (ORCID: https://orcid.org/0000-0003-1874-6356)
- Monika C. Wolkers (ORCID: https://orcid.org/0000-0003-3242-1363)
- Žan Hozjan
- Veronica Kot
- Aniek A. M. Martens
- Igor Ruiz de los Mozos
- Randall S. Johnson
- Yumna A. Butt
Institutions
- Radboud University Nijmegen (NL)
- University of Cambridge (GB)
- The Francis Crick Institute (GB)
- Radboud University Medical Center (NL)
- Karolinska Institutet (SE)
- The Netherlands Cancer Institute (NL)
- Sanquin (NL)
- Amsterdam Neuroscience (NL)
- Radboud Institute for Molecular Life Sciences (NL)
- Oncode Institute (NL)
- NIHR Queen Square Dementia Biomedical Research Unit (GB)
- National Hospital for Neurology and Neurosurgery (GB)
- National Institute of Chemistry (SI)
- University College London (GB)
- Universidade Nova de Lisboa (PT)
- University of Amsterdam (NL)
Publication Details
- Journal
- Nature Communications
- Published
- 2026-01-22
- DOI
- https://doi.org/10.1038/s41467-025-67762-w
- Citations
- 1
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 22.24
Funders
- Wellcome Trust
- Francis Crick Institute
- National Institute for Health and Care Research
- Cancerfonden
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Vetenskapsrådet
- Barncancerfonden
- Oncode Institute
- Directorate for Biological Sciences
- Medical Research Council